Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Predicted Annual Growth Rate of the Predictive Biomarkers Market Over the Coming Decade?

In the past few years, the predictive biomarkers market size has seen consistent growth. It is projected to rise from $20.05 billion in 2024 to $20.96 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 4.5%. This growth in the historical period is credited to factors such as the rise in research and development investments, enhancements in healthcare infrastructure, partnerships between academia and industry, a growing number of cancer and genetic disorder cases, and the increased application of biomarkers in developing drugs.

Over the next couple of years, a steady increase in the predictive biomarkers market size is anticipated. By 2029, the sector is projected to be valued at $24.67 billion, reflecting a compound annual growth rate (CAGR) of 4.2%. This growth, projected over the forecast period, can be associated with factors such as the rising adoption of precision medicine, increased emphasis on preventive healthcare, growing healthcare spending, increased funding in biomarker-based diagnostics, expansion of biobanks and tissue banks, and heightened global health awareness. Significant trends during the forecast period include incorporation of artificial intelligence into biomarker evaluation, enhancement of non-invasive biomarker testing, breakthroughs in biomarker-driven digital health gadgets, advancement in single-cell sequencing technologies, development of real-time biosensing and monitoring systems, and progress in bioinformatics tools for data integration.

What Strategic Factors Are Influencing the Accelerated Growth of the Predictive Biomarkers Market?

The anticipated increase in cancer incidences is forecasted to fuel the expansion of the predictive biomarkers market. Cancer, a condition defined by the unchecked proliferation of cells that can infiltrate and metastasize to other body areas, is escalating mainly due to the aging demographic, shifts in lifestyle, and heightened exposure to risk elements like tobacco, unhealthy nutrition, and environmental contaminants. Cancer’s predictive biomarkers assist in pinpointing patients who are likely to react to specific therapies, facilitating a more personalized and efficient treatment. For instance, the International Agency for Research on Cancer (IARC), a French affiliate of the World Health Organization (WHO) devoted to cancer research, reported in April 2024 that there were close to 20 million fresh instances of cancer and roughly 10 million cancer-related fatalities in 2022. Additionally, forecasts suggest a rise to 35 million new cancer cases annually by 2050, marking a 77% increase from 2022. Thus, the ascending trajectory of cancer cases is anticipated to steer the growth of the predictive biomarkers market.

Request Your Free Predictive Biomarkers Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=20595&type=smp

What Are the Major Players Making an Impact in the Predictive Biomarkers Market’s Growth?

Major companies operating in the predictive biomarkers market are:

• Johnson & Johnson Services Inc

• F Hoffmann-La Roche Ltd

• Thermo Fisher Scientific Inc

• Abbott Laboratories

• Danaher Corporation

Which Upcoming Trends Are Set to Influence the Predictive Biomarkers Market’s Path Forward?

The predictive biomarkers market’s leading corporations are concentrating on speeding up biomarker creation through technological progress, like artificial intelligence (AI)-powered biomarker discovery. This strategy allows them to maintain a competitive advantage by providing more personalized and efficient therapies at a faster pace. AI-powered biomarker discovery makes it possible to analyze extensive and intricate datasets, giving way to the recognition of predictive biomarkers that may not be obvious using conventional techniques. For example, in July 2024, Scipher Medicine, Inc., a precision immunology organization based in the US, launched PRoBeNet (Predictive Response Biomarkers using Network Medicine). This tool is designed to expedite the development of predictive response biomarkers for intricate diseases by leveraging AI and network biology. PRoBeNet determines biomarkers of therapy response by incorporating therapy-targeted proteins and disease-specific molecular trademarks. It has been verified for autoimmune diseases like rheumatoid arthritis, ulcerative colitis, and Crohn’s disease and is versatile enough to be applied to other complicated diseases and stages of drug development.

Secure Your Global Predictive Biomarkers Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/predictive-biomarkers-global-market-report

Which Key Segments of the Predictive Biomarkers Market Are Poised for Growth and Innovation?

The predictive biomarkers market covered in this report is segmented –

1) By Indication: Cancer, Metabolic Disease, Cardiovascular Disorder, Immunological Disorder, Other Indications

2) By Application: Screening, Analysis, Diagnosis, Prediction, Monitoring

3) By End User: Diagnostic Centers, Contract Research Organizations, Academic Research Institutes, Pharms And Biotech Companies, Other End Users

Subsegments:

1) By Cancer: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Ovarian Cancer, Leukemia And Lymphoma, Melanoma, Pancreatic Cancer, Kidney Cancer, Head And Neck Cancer

2) By Metabolic Disease: Type 1 and Type 2 Diabetes, Obesity, Metabolic Syndrome, Non-Alcoholic Fatty Liver Disease (NAFLD), Dyslipidemia, Insulin Resistance

3) By Cardiovascular Disorder: Atherosclerosis, Coronary Artery Disease, Heart Failure, Myocardial Infarction (Heart Attack), Arrhythmia, Hypertension, Stroke, Peripheral Arterial Disease

4) By Immunological Disorder: Autoimmune Diseases, Inflammatory Bowel Disease (IBD), Multiple Sclerosis, Psoriasis, Allergic Diseases, Asthma, Chronic Obstructive Pulmonary Disease (COPD), Immunodeficiency Disorders

5) By Other Indications: Neurological Disorders, Infectious Diseases, Renal Diseases, Osteoarthritis, Genetic Disorders, Respiratory Disorders

What Regions Are Steering Growth in the Predictive Biomarkers Sector?

North America was the largest region in the predictive biomarkers market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Predictive Biomarkers Market Classified and Defined in Market Analysis?

Predictive biomarkers refer to biological indicators that help predict an individual’s likelihood of developing a disease or their response to a specific treatment. They can be genetic, proteomic, or molecular markers that provide insights into disease susceptibility or treatment efficacy and the advantage of tailoring treatments to individual patients, enhancing the effectiveness of interventions, and potentially reducing adverse effects by identifying those most likely to benefit from specific therapies.

Browse Through More Similar Reports By The Business Research Company:

Renal Biomarkers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

Renal Biomarkers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report

Cancer Biomarker Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: